Study on new defibrillator leads for heart pacing
Part of Heart & circulation clinical trials.
This trial is testing a new type of defibrillator lead (the wire that connects a defibrillator to the heart) that is designed for pacing the heart's natural electrical system. It aims to see if this approach works well and is safe for people who need cardiac resynchronization therapy (CRT), a treatment that helps the heart beat in a more coordinated way.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been told you need cardiac resynchronization therapy (CRT) based on current heart guidelines.
- Your doctor is planning to try a specific type of defibrillator lead called LBBAP (left bundle branch area pacing) for the first time.
- You have health insurance through the national healthcare system.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to place a pacemaker lead in the left bundle branch area of the heart. It may help people who need a pacemaker to see if this approach is safe and works well.
This study tests a new pacing lead designed to be placed in the wall between the heart's lower chambers (septum). It aims to see if this lead is safe and works well for people who need a new pacemaker.
This trial tests a new way to use an ECG (electrical heart recording) to predict who will benefit from a special pacemaker called cardiac resynchronization therapy (CRT). It is for people with heart failure and a specific heart rhythm problem.
This trial tests a special pacing method for people with heart failure. It aims to improve the heart's pumping by using a more natural pacing approach.
This trial tests a pacing approach designed to improve how the heart beats in some people with heart failure and a specific heart rhythm pattern on ECG. If you already need a device (CRT-D) based on your results, the study may help see whether this pacing correction improves outcomes.
This trial tests a noninvasive way to map your heart’s wiring and veins to help guide placement of a heart resynchronization therapy (CRT) device. If you have certain abnormal heart rhythm and weak heart pumping, it may help doctors place the therapy more accurately and safely.
Hear when a new Cardiac Resynchronization Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.